{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:13:59Z","timestamp":1789107239795,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijcard.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T01:57:40Z","timestamp":1567735060000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus"],"prefix":"10.1016","volume":"297","author":[{"given":"Dimitrios","family":"Farmakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiuseppe","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loant","family":"Baholli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Bautin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Comin-Colet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Crespo-Leiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Garc\u00eda-Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grigioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Grucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Hasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Herpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios K.","family":"Iliodromitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristjan","family":"Karason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Kivikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Liaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Ljubas-Ma\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Masip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Ostadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti","family":"P\u00f5der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Pollesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftihia","family":"Polyzogopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"P\u00f6lzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tschope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjut","family":"Varpula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"von Lewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Vrtovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Birhan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endre","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.09.005_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijcard.2015.08.030","article-title":"In-hospital management of acute heart failure: practical recommendations and future perspectives","volume":"201","author":"Farmakis","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2019.09.005_bb0010","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"12","key":"10.1016\/j.ijcard.2019.09.005_bb0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"issue":"6A","key":"10.1016\/j.ijcard.2019.09.005_bb0020","doi-asserted-by":"crossref","first-page":"47G","DOI":"10.1016\/j.amjcard.2005.07.021","article-title":"Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes","volume":"96","author":"Bayram","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.005_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/17482940802262376","article-title":"The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study","volume":"10","author":"Rossinen","year":"2008","journal-title":"Acute Card. Care"},{"issue":"21","key":"10.1016\/j.ijcard.2019.09.005_bb0030","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00134-010-2073-4","article-title":"Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods","volume":"37","author":"Mebazaa","year":"2011","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ejhf.991","article-title":"ESC Heart Failure Long-Term Registry Investigators. Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry","volume":"20","author":"Mebazaa","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-007-9014-5","article-title":"Classical inotropes and new cardiac enhancers","volume":"12","author":"Parissis","year":"2007","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.ijcard.2019.09.005_bb0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"Yancy","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2019.09.005_bb0055","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ijcard.2019.09.005_bb0060","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/eurjhf\/hfq138","article-title":"Acute pulmonary oedema: clinical characteristics, prognostic factors, and in-hospital management","volume":"12","author":"Parissis","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"22","key":"10.1016\/j.ijcard.2019.09.005_bb0065","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur. Heart J."},{"issue":"27","key":"10.1016\/j.ijcard.2019.09.005_bb0070","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.005_bb0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0009-9236(97)90139-9","article-title":"Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers","volume":"61","author":"Ukkonen","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ijcard.2019.09.005_bb0080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"NEJM 2010;362(9):779\u201389. Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.005_bb0090","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/01.ane.0000256863.92050.d3","article-title":"The effects of levosimendan in cardiac surgery patients with poor left ventricular function","volume":"104","author":"de Hert","year":"2007","journal-title":"Anesth. Analg."},{"issue":"3","key":"10.1016\/j.ijcard.2019.09.005_bb0095","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1996.tb15716.x","article-title":"Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs","volume":"119","author":"Pagel","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan","volume":"159","author":"Papp","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.005_bb0105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2016.07.202","article-title":"Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper","volume":"222","author":"Farmakis","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.005_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2016.02.014","article-title":"Levosimendan meta-analyses: is there a pattern in the effect on mortality?","volume":"209","author":"Pollesello","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1074248406289286","article-title":"Effect of levosimendan and milrinone on regional myocardial ischemia\/reperfusion-induced arrhythmias in dogs","volume":"11","author":"Papp","year":"2006","journal-title":"J.\u00a0Cardiovasc. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.ijcard.2019.09.005_bb0120","first-page":"2732","article-title":"Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock","volume":"35","author":"Russ","year":"2007","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.ijcard.2019.09.005_bb0125","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10741-007-9008-3","article-title":"An introduction to acute heart failure syndromes: definition and classification","volume":"12","author":"Filippatos","year":"2007","journal-title":"Heart Fail. Rev."},{"issue":"10","key":"10.1016\/j.ijcard.2019.09.005_bb0135","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurjhf\/hfq154","article-title":"EURObservational research programme: the Heart Failure Pilot Survey (ESC-HF pilot)","volume":"12","author":"Maggioni","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.005_bb0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2019.09.005_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.005_bb0150","series-title":"The ESC Textbook of Cardiovascular Medicine","article-title":"Acute heart failure \u2013 Treatment","author":"Farmakis","year":"2018"},{"key":"10.1016\/j.ijcard.2019.09.005_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cce2.59","article-title":"Inotropes in acute heart failure","volume":"3","author":"Bistola","year":"2017","journal-title":"Continuing Cardiology Education"},{"issue":"6","key":"10.1016\/j.ijcard.2019.09.005_bb0160","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.005_bb0165","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/bja\/aeu446","article-title":"A\u00a0Bayesian network meta-analysis on the effect of inodilatory agents on mortality","volume":"114","author":"Greco","year":"2015","journal-title":"Br. J. Anaesth."},{"issue":"10","key":"10.1016\/j.ijcard.2019.09.005_bb0170","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What is the role of beta-adrenergic signaling in heart failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.ijcard.2019.09.005_bb0175","doi-asserted-by":"crossref","first-page":"e71659","DOI":"10.1371\/journal.pone.0071659","article-title":"GREAT network. The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis","volume":"8","author":"Pirracchio","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijcard.2019.09.005_bb0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ejhf.9","article-title":"Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms","volume":"16","author":"Fedele","year":"2014","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.005_bb0185","first-page":"432","article-title":"Inotropes in cardiac patients: update 2011","volume":"16","author":"Parissis","year":"2010","journal-title":"Curr. Opin. Crit. Care"},{"issue":"10","key":"10.1016\/j.ijcard.2019.09.005_bb0190","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou","year":"2013","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00134-015-4041-5","article-title":"Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance","volume":"42","author":"Mebazaa","year":"2016","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.ijcard.2019.09.005_bb0200","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients","volume":"44","author":"L\u00e9opold","year":"2018","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.005_bb0205","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1053\/j.jvca.2018.04.019","article-title":"Comparison of levosimendan and milrinone for ECLS weaning in patients after cardiac surgery-a retrospective before-and-after study","volume":"32","author":"Jacky","year":"2018","journal-title":"J.\u00a0Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.ijcard.2019.09.005_bb0210","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","volume":"1","author":"Schumann","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"19","key":"10.1016\/j.ijcard.2019.09.005_bb0215","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2014.02.552","article-title":"Heart failure: TNM-like classification","volume":"63","author":"Fedele","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ehf2.12114","article-title":"Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting","volume":"4","author":"Chernomordik","year":"2017","journal-title":"ESC Heart Fail"},{"issue":"9","key":"10.1016\/j.ijcard.2019.09.005_bb0225","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jchf.2018.03.019","article-title":"Ambulatory inotrope infusions in advanced heart failure: a systematic review and meta-analysis","volume":"6","author":"Nizamic","year":"2018","journal-title":"JACC Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0230","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2014.04.111","article-title":"Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus","volume":"174","author":"Nieminen","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2019.09.005_bb0235","first-page":"1768","article-title":"Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure","volume":"92","author":"Parissis","year":"2006","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ijcard.2019.09.005_bb0240","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.amjcard.2004.11.033","article-title":"Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone","volume":"95","author":"Nanas","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2019.09.005_bb0245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijcard.2011.03.013","article-title":"Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure","volume":"159","author":"Bonios","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/FJC.0b013e31819846cd","article-title":"Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure","volume":"53","author":"Drakos","year":"2009","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2019.09.005_bb0255","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2015.08.188","article-title":"Repeated or intermittent levosimendan treatment in advanced heart failure: an updated meta-analysis","volume":"202","author":"Silvetti","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2019.09.005_bb0260","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.118","article-title":"Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial","volume":"16","author":"Altenberger","year":"2014","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.ijcard.2019.09.005_bb0265","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ejhf.1145","article-title":"Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial","volume":"20","author":"Com\u00edn-Colet","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.005_bb0270","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ehf2.12177","article-title":"Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta-analysis of randomized trials","volume":"4","author":"Silvetti","year":"2017","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2019.09.005_bb0275","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ehf2.12366","article-title":"Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period","volume":"6","author":"P\u00f6lzl","year":"2019","journal-title":"ESC Heart Fail."},{"issue":"14","key":"10.1016\/j.ijcard.2019.09.005_bb0280","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.107.690768","article-title":"Patterns of weight change preceding hospitalization for heart failure","volume":"116","author":"Chaudhry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.09.005_bb0285","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijcard.2017.05.081","article-title":"Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy","volume":"243","author":"P\u00f6lzl","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2019.09.005_bb0290","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurjhf\/hft071","article-title":"Preferences of heart failure patients in daily clinical practice: quality of life or longevity?","volume":"15","author":"Kraai","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2019.09.005_bb0295","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijcard.2015.04.235","article-title":"The patient perspective: quality of life in advanced heart failure with frequent hospitalisations","volume":"191","author":"Nieminen","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.005_bb0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/eurjhf\/hfn032","article-title":"Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure","volume":"11","author":"Parissis","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.005_bb0305","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","article-title":"Rehospitalization for heart failure: problems and perspectives","volume":"61","author":"Gheorghiade","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2019.09.005_bb0310","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehr306","article-title":"Effects of person-centred care in patients with chronic heart failure: the PCC-HF study","volume":"33","author":"Ekman","year":"2012","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2019.09.005_bb0315","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cardfail.2007.04.004","article-title":"A\u00a06-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure","volume":"13","author":"Mavrogeni","year":"2007","journal-title":"J.\u00a0Card. Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.005_bb0320","first-page":"269","article-title":"Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period","volume":"50","author":"Papadopoulou","year":"2009","journal-title":"Hell. J. Cardiol."},{"issue":"Suppl I","key":"10.1016\/j.ijcard.2019.09.005_bb0325","doi-asserted-by":"crossref","first-page":"I11","DOI":"10.1093\/eurheartj\/suy040","article-title":"Repetitive levosimendan treatment in the management of advanced heart failure","volume":"20","author":"Oliva","year":"2018","journal-title":"Eur. Heart J. Suppl."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319325021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319325021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:44:12Z","timestamp":1759092252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319325021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":65,"alternative-id":["S0167527319325021"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.005","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}